DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Lamond NW. et al.
Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer.
Breast cancer research and treatment 2012;
133: 1115-1123
We do not assume any responsibility for the contents of the web pages of other providers.